As April gives way to May, the market braces for a blockbuster week packed with earnings from some of the biggest names ...

Abbott (NYSE: ABT) today announced new study data demonstrating the safety and efficacy of its Volt pulsed field ablation ...

Boston Scientific today shared new clinical data supporting multiple therapies at the Heart Rhythm Society (HRS) 2025 Meeting ...

Modern life makes us tired, right? But research from societies in Africa and South America suggests people in the ancient ...

A new study explores how brain networks differ between patients in early and chronic stages of psychosis, shedding light on ...

Modern life makes us tired, right? But research from societies in Africa and South America suggests people in the ancient ...

While management did not quantify any potential tariff exposure, it did signal that the effect would be in line with the ...

Gilead Sciences' Q1 2025 earnings reveal challenges in oncology and Veklury sales, while HIV therapies remain strong. See why ...

A new study has uncovered the brain connectivity patterns that differentiate patients who recover from psychosis from those ...

We expect investors to focus on Beam Therapeutics’ BEAM progress in developing its pipeline candidates, which are being ...

A reform was presented to the Mexican Senate to bar foreign governments from spreading propaganda after the U.S. DHS airs anti-migrant ad campaign ...